HK1148931A1 - 具有可生物侵蝕基質芯和可生物侵蝕皮的注射用緩釋植入劑 - Google Patents

具有可生物侵蝕基質芯和可生物侵蝕皮的注射用緩釋植入劑

Info

Publication number
HK1148931A1
HK1148931A1 HK11103212.3A HK11103212A HK1148931A1 HK 1148931 A1 HK1148931 A1 HK 1148931A1 HK 11103212 A HK11103212 A HK 11103212A HK 1148931 A1 HK1148931 A1 HK 1148931A1
Authority
HK
Hong Kong
Prior art keywords
drug
skin
core
bioerodible
polymer
Prior art date
Application number
HK11103212.3A
Other languages
English (en)
Inventor
Kang-Jye Chou
Hong Guo
Paul Ashton
Robert W Shimizu
David A Watson
Original Assignee
Psivida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/714,549 external-priority patent/US8871241B2/en
Application filed by Psivida Inc filed Critical Psivida Inc
Publication of HK1148931A1 publication Critical patent/HK1148931A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Prostheses (AREA)
HK11103212.3A 2003-11-13 2011-03-29 具有可生物侵蝕基質芯和可生物侵蝕皮的注射用緩釋植入劑 HK1148931A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/714,549 US8871241B2 (en) 2002-05-07 2003-11-13 Injectable sustained release delivery devices
US54336804P 2004-02-09 2004-02-09

Publications (1)

Publication Number Publication Date
HK1148931A1 true HK1148931A1 (zh) 2011-09-23

Family

ID=34636703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103212.3A HK1148931A1 (zh) 2003-11-13 2011-03-29 具有可生物侵蝕基質芯和可生物侵蝕皮的注射用緩釋植入劑

Country Status (20)

Country Link
EP (2) EP1696822B1 (zh)
JP (3) JP5661226B2 (zh)
AT (1) ATE460901T1 (zh)
AU (1) AU2004292957C1 (zh)
CA (1) CA2545650C (zh)
CY (1) CY1114947T1 (zh)
DE (1) DE602004026106D1 (zh)
DK (1) DK1696822T3 (zh)
ES (2) ES2447816T7 (zh)
FR (1) FR14C0042I1 (zh)
HK (1) HK1148931A1 (zh)
IL (1) IL175584A (zh)
MX (1) MXPA06005431A (zh)
NO (1) NO20062362L (zh)
NZ (3) NZ547619A (zh)
PL (2) PL1696822T3 (zh)
PT (2) PT2233112E (zh)
SI (1) SI1696822T1 (zh)
TW (2) TWI496597B (zh)
WO (1) WO2005051234A2 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
DK1696822T3 (da) 2003-11-13 2010-05-17 Psivida Inc Injicerbart vedvarende frigørelsesimplantat, som har en bioeroderbar matrixkerne og en bioeroderbar hus
EP3470108A1 (en) 2004-07-02 2019-04-17 Mati Therapeutics Inc. Treatment medium delivery device for delivery of treatment media to the eye
WO2007076358A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
CN103393483B (zh) 2006-03-31 2016-08-24 玛提治疗有限公司 用于鼻泪系统的药物释放方法、结构及组合物
UA97971C2 (ru) 2007-06-08 2012-04-10 Берингер Ингельхайм Интернациональ Гмбх Препарат невирапина пролонгированного высвобождения
CN101861135A (zh) 2007-09-07 2010-10-13 Qlt栓塞输送公司 泪道植入物检测
FR2927798B1 (fr) * 2008-02-25 2011-03-04 C L Investissements Procede de fabrication d'un dispositif contraceptif intra-uterin et installation pour la mise en oeuvre de ce procede
US8858983B2 (en) 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US20110238036A1 (en) * 2009-12-23 2011-09-29 Psivida Us, Inc. Sustained release delivery devices
AU2011237788A1 (en) * 2010-04-06 2012-11-01 Allergan, Inc. Sustained-release reservoir implants for intracameral drug delivery
CA2798084A1 (en) 2010-05-17 2011-11-24 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
EP2673049A4 (en) * 2011-02-11 2015-04-08 Psivida Inc METHOD FOR THE TREATMENT OF MOLECULAR SOILS WITH ANTIOTE THERAPEUTICS
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP6100782B2 (ja) 2011-08-29 2017-03-22 キューエルティー インコーポレイテッド 緑内障および高眼圧症を治療するための活性剤の徐放送達
AU2012300908A1 (en) 2011-08-30 2014-04-17 Universiteit Gent Multi-layered release formulation
EP2854890B1 (en) * 2012-05-30 2019-02-06 Boston Scientific Scimed, Inc. Injectable biodegradable particles for controlled therapeutic agent release
CN107106509B (zh) 2014-12-18 2021-11-30 帝斯曼知识产权资产管理有限公司 用于递送酸敏感药物的药物递送系统
CN117959239A (zh) * 2017-06-13 2024-05-03 视点制药公司 可生物侵蚀的药物递送装置
FR3085841B1 (fr) * 2018-09-14 2020-12-04 Oreal Procede de preparation de capsules et systeme associe
EP3698841A1 (en) * 2019-02-19 2020-08-26 L'oreal Injection device
AU2021236658A1 (en) * 2020-03-17 2022-11-10 Aron H. BLAESI Expandable, multi-excipient structured dosage form for prolonged drug release

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6051576A (en) 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5518672A (en) 1994-05-31 1996-05-21 Randcastle Extrusion Systems, Inc. Extrusion surge controller and method
US5486328A (en) 1994-05-31 1996-01-23 Randcastle Extrusion Systems, Inc. Extrusion surge suppressor and method
US5569429A (en) 1995-05-05 1996-10-29 Randcastle Extrusion Systems, Inc. Dynamic seal and sealing method
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
SE0001893D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab Medical arrangement
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
EP1458352A1 (en) * 2001-12-18 2004-09-22 Novo Nordisk A/S Solid dose micro implant
DK1696822T3 (da) 2003-11-13 2010-05-17 Psivida Inc Injicerbart vedvarende frigørelsesimplantat, som har en bioeroderbar matrixkerne og en bioeroderbar hus

Also Published As

Publication number Publication date
SI1696822T1 (sl) 2010-07-30
PL2233112T3 (pl) 2014-05-30
CY1114947T1 (el) 2016-12-14
EP2233112B3 (en) 2014-05-14
NZ581461A (en) 2011-04-29
TW200526285A (en) 2005-08-16
PT2233112E (pt) 2014-02-27
AU2004292957B2 (en) 2010-09-09
EP2233112A2 (en) 2010-09-29
DK1696822T3 (da) 2010-05-17
JP5526114B2 (ja) 2014-06-18
PL2233112T6 (pl) 2014-11-28
NZ575950A (en) 2010-06-25
ES2340389T3 (es) 2010-06-02
TW201422269A (zh) 2014-06-16
JP5918195B2 (ja) 2016-05-18
JP5661226B2 (ja) 2015-01-28
ATE460901T1 (de) 2010-04-15
CA2545650A1 (en) 2005-06-09
TWI445559B (zh) 2014-07-21
JP2007512248A (ja) 2007-05-17
WO2005051234A2 (en) 2005-06-09
EP2233112B1 (en) 2013-11-20
CA2545650C (en) 2015-08-18
MXPA06005431A (es) 2007-01-25
AU2004292957A1 (en) 2005-06-09
JP2014040479A (ja) 2014-03-06
IL175584A0 (en) 2006-09-05
PL1696822T3 (pl) 2010-08-31
WO2005051234A3 (en) 2005-11-10
EP1696822A2 (en) 2006-09-06
PT1696822E (pt) 2010-04-28
TWI496597B (zh) 2015-08-21
EP2233112A3 (en) 2011-03-02
NO20062362L (no) 2006-08-13
NZ547619A (en) 2009-06-26
ES2447816T7 (es) 2014-06-25
ES2447816T3 (es) 2014-03-13
JP2012072180A (ja) 2012-04-12
AU2004292957C1 (en) 2011-04-28
FR14C0042I1 (fr) 2014-06-27
DE602004026106D1 (de) 2010-04-29
IL175584A (en) 2015-05-31
EP1696822B1 (en) 2010-03-17

Similar Documents

Publication Publication Date Title
HK1148931A1 (zh) 具有可生物侵蝕基質芯和可生物侵蝕皮的注射用緩釋植入劑
Teoh et al. Fabricating scalable, personalized wound dressings with customizable drug loadings via 3D printing
AU651084B2 (en) Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
CA2139058C (en) Controlled release drug formulation
Johnson et al. Drug eluting implants in pharmaceutical development and clinical practice
DE60017956D1 (de) Biodegradierbare polymerzusammensetzung
ATE421316T1 (de) Herstellung von langzeit- arzneimittelabgabevorrichtungen mit polymeren auf polyurethanbasis
EP2594259A1 (en) Methods for manufacturing delivery devices and devices thereof
ES2093625T3 (es) Administracion extendida de farmaco de moleculas pequeñas solubles en agua.
FR2764514B1 (fr) Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
CN108601932A (zh) 微针阵列和微针片
Masood Application of fused deposition modelling in controlled drug delivery devices
CN102264524A (zh) 模制套管与小深孔
PT1638534E (pt) Uso de etanol como plastificante para preparar implantes subcutâneos contendo princípios activos termolabiais dispersados numa matriz plga
IN2012DN04939A (zh)
EP2558271A1 (de) Kanülenvorrichtung und verfahren und vorrichtung zum bestücken einer kanülenvorrichtung mit einem implantat
CY1114534T1 (el) Συσκευες ενεσιμης χορηγησης με παρατεταμενη αποδεσμευση
US20240277907A1 (en) Compositions of extended release coatings and methods for applying extended release coatings
CN1557501A (zh) 医用外科固定用绷带、指套及其制备方法
CN1209169C (zh) 医用外科固定材料及其制备方法
TW200500094A (en) Sustained release dosage forms of anesthetics for pain management